Quince Therapeutics, Inc. — 8-K Filings
62 8-K filings on record
This page lists all 8-K filings submitted to the SEC by Quince Therapeutics, Inc. (QNCX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Quince Therapeutics, Inc. has filed 62 8-K documents with the SEC since 2016. To view all SEC filings by Quince Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
POS AM
POS EX
POSASR
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-21-043200 | Feb 16, 2021 | Feb 12, 2021 |
| 8-K | 8-K | 0001193125-21-036344 | Feb 10, 2021 | Feb 9, 2021 |
| 8-K | 8-K | 0001193125-21-017064 | Jan 26, 2021 | — |
| 8-K | 8-K | 0001193125-21-016445 | Jan 25, 2021 | Jan 19, 2021 |
| 8-K | 8-K | 0001193125-20-310020 | Dec 4, 2020 | — |
| 8-K | 8-K | 0001193125-20-165699 | Jun 10, 2020 | Jun 8, 2020 |
| 8-K | 8-K | 0001193125-20-148723 | May 21, 2020 | May 18, 2020 |
| 8-K | 8-K | 0001193125-20-140538 | May 12, 2020 | — |
| 8-K | 8-K | 0001193125-20-128936 | Apr 30, 2020 | Apr 27, 2020 |
| 8-K | 8-K | 0001193125-20-075778 | Mar 17, 2020 | — |
| 8-K | 8-K | 0001193125-20-026290 | Feb 6, 2020 | Feb 5, 2020 |
| 8-K | FORM 8-K | 0001193125-19-145468 | May 13, 2019 | — |